Bio-Works Technologies AB (BIOWKS) Price & Analysis

0 Followers

BIOWKS Stock Chart & Stats

kr3.33

-kr0.03(-1.90%)

At close: Mar 06 4:00 PM EST

kr3.33

-kr0.03(-1.90%)

Day’s Range― - ―

52-Week Rangekr1.47 - kr4.98

Previous CloseN/A

Volume20.36K

Average Volume (3M)70.02K

Market Cap

kr316.17M

Enterprise Valuekr99.24M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.54

Next Earnings

Aug 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.05

Shares Outstanding99,424,590

10 Day Avg. Volume46,662

30 Day Avg. Volume70,017

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

BIOWKS FAQ

What was Bio-Works Technologies AB’s price range in the past 12 months?

Bio-Works Technologies AB lowest stock price was kr1.47 and its highest was kr4.98 in the past 12 months.

What is Bio-Works Technologies AB’s market cap?

Bio-Works Technologies AB’s market cap is kr316.17M.

When is Bio-Works Technologies AB’s upcoming earnings report date?

Bio-Works Technologies AB’s upcoming earnings report date is Aug 21, 2026 which is in 47 days.

How were Bio-Works Technologies AB’s earnings last quarter?

Bio-Works Technologies AB released its earnings results on May 14, 2026. The company reported kr0.047 earnings per share for the quarter, beating the consensus estimate of N/A by kr0.047.

Is Bio-Works Technologies AB overvalued?

According to Wall Street analysts Bio-Works Technologies AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Bio-Works Technologies AB pay dividends?

Bio-Works Technologies AB does not currently pay dividends.

What is Bio-Works Technologies AB’s EPS estimate?

Bio-Works Technologies AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Bio-Works Technologies AB have?

Bio-Works Technologies AB has 99,424,590 shares outstanding.

What happened to Bio-Works Technologies AB’s price movement after its last earnings report?

Bio-Works Technologies AB reported an EPS of kr0.047 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Bio-Works Technologies AB?

Currently, no hedge funds are holding shares in SE:BIOWKS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Bio-Works Technologies AB

Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.